Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jade Biosciences closed a public offering of 11.5 million shares of common stock at $15.00 per share, including the full exercise of the underwriters' option to purchase an additional 1.5 million shares. The company raised gross proceeds of $172.5 million, which it intends to use to fund clinical trials, preclinical studies, manufacturing, and general corporate purposes.
Key figures
- Deal Value Usd
- 172500000
- Offering Price
- 15
- Shares Offered
- 11500000
- Additional shares from option
- 1500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.